Four checks before you vaccinate
-
Is the dog well today?
If the dog is systemically unwell or the underlying disease is unstable, defer routine vaccination and reassess once the condition is controlled.
-
Which treatment is being given?
Check the drugs, dose, duration and recent changes. Glucocorticoids alone and potent immunosuppressive or antineoplastic regimens require different assessments.
-
What is documented?
Review the primary core series and subsequent boosters. In a previously vaccinated adult, suitable CDV, CAV and CPV antibody tests may help assess whether another core viral dose is needed.
-
Which vaccine is due?
Check the product and formulation, exposure risk and legal requirements. A modified-live core vaccine, an inactivated leptospirosis vaccine and rabies vaccination call for separate decisions.
What should happen today?
| Clinical finding | Next step |
|---|---|
| Systemic illness or uncontrolled immune-mediated disease | Defer routine vaccination. Review again when the dog is clinically stable. |
| Stable disease, glucocorticoid treatment | Check the regimen and timing. Vaccination may be possible during stable treatment, but the underlying condition and previous vaccination history still matter. |
| Potent immunosuppressive or antineoplastic treatment | Seek specialist advice. For a previously vaccinated adult, generally delay a routine modified-live core booster. Consider suitable core viral serology. If a modified-live core booster is needed, WSAVA suggests waiting at least three months after potent treatment ends. |
| Leptospirosis vaccine due | Review local exposure risk and previous doses. An inactivated vaccine presents a different concern from a modified-live vaccine, but the immune response may be reduced. Decide individually. |
| Rabies vaccination due | Check the product and local legal requirements. Antibody testing does not automatically replace a legally required vaccination. |
For a different patient
For a patient with a different vaccination history, Vetool can organize possible vaccine actions, safety holds and follow-up windows using the details you enter. It does not assess specific immunosuppressive drugs or doses.
Worked example: a dog on potent immunosuppression
Patient: 6-year-old dog, clinically well, receiving a potent immunosuppressive regimen for an immune-mediated condition.
Records: Primary core series and later boosters documented. DA2P and leptospirosis are marked due; rabies is current.
| Vaccine | Decision at this visit |
|---|---|
| DA2P | Do not give the booster automatically. Review the record, consider CDV/CAV/CPV serology and discuss timing with the clinician managing treatment. |
| Leptospirosis | Check local risk, previous doses and whether vaccination during treatment is appropriate. Its inactivated formulation changes the assessment, but does not guarantee a full immune response. |
| Rabies | No dose is due today. Keep the legal renewal date in the plan. |
Document before the dog leaves: the treatment regimen, the decision for each vaccine, reasons for any deferral and the planned reassessment. Discuss reducing relevant exposure while protection is uncertain.
Glucocorticoids: when to revisit vaccination
WSAVA reports that glucocorticoids alone have not substantially suppressed vaccine antibody responses in the studies reviewed. It still recommends reassessing vaccination after treatment, especially if the initial core series was given during therapy.
| Treatment situation | WSAVA guidance |
|---|---|
| Short course has ended | Revaccination, when indicated, at least 2 weeks after treatment stops. |
| Longer course has ended | The interval may extend to 3 months, depending on the course and clinical judgment. |
| Treatment cannot be stopped | Consider vaccination only after the disease has been well controlled on a stable glucocorticoid dose for several weeks. |
If the dog already received its core vaccines, suitable antibody testing for CDV, CAV and CPV may help avoid an unnecessary repeat dose. This does not settle leptospirosis or rabies decisions.
Use the checklist for the next patient
For a patient with different vaccine records, immune status or exposure risks, Vetool can bring the possible actions, holds and next appointment windows into one vaccination plan. Check the selected product label and local requirements before administration.
References
Clinical use
For veterinary professional education and workflow support. Apply patient-specific clinical judgment, current product information and local requirements.